A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause
Clinical trial NCT06812754 · COMPLETED
Trial details
- NCT number
- NCT06812754
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2026-02-11
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.